Mark Frans van Coeverden de Groot

Vorstandsvorsitzender bei Pattern Pharma, Inc.

Health Technology

Ursprung des Netzwerks ersten Grades von Mark Frans van Coeverden de Groot

Einheit	Art der Einheit	Industrie
Pattern Pharma, Inc. Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. 6	Holding Company	Pharmaceuticals: Major	6

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Mark Frans van Coeverden de Groot

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
I-Flow Corp. I-Flow Corp. Medical SpecialtiesHealth Technology I-Flow Corp. designs, develops and manufactures ambulatory drug delivery systems. Its products include portable infusion pumps, catheters and pain kits. The company was founded in 1985 and is headquartered in Lake Forest, CA.	Medical Specialties	John H. Abeles	Director/Board Member
ORYX TECHNOLOGY CORP.	Electrical Products	John H. Abeles	Director/Board Member
DUSA Pharmaceuticals, Inc. DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.	Pharmaceuticals: Major	John H. Abeles	Director/Board Member
Northlea Partners LLLP		John H. Abeles	Corporate Officer/Principal
COMBIMATRIX CORP	Biotechnology	John H. Abeles	Director/Board Member
Viventia Biotech, Inc. Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada	Biotechnology	Nick Glover	Chief Executive Officer
Alison Raffaele Cosmetics, Inc. Alison Raffaele Cosmetics, Inc. Specialty StoresRetail Trade Alison Raffaele Cosmetics, Inc. manufactures cosmetics and facial makeup products. Its products include powder, lipstick, lip gloss and blush, tools, and brushes. The firm was founded by Alison Raffaele Tatem in 2000 and is headquartered in Cliffside Park, NJ.	Specialty Stores	John H. Abeles	Director/Board Member
NEUROTROPE, INC.	Pharmaceuticals: Major	John H. Abeles	Chairman
Lumira Capital Investment Management, Inc. Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.	Investment Managers	Nick Glover	Chief Investment Officer
MEI PHARMA, INC.	Pharmaceuticals: Major	Nick Glover	Director/Board Member
University of Cambridge	College/University	Hans S. Keirstead	Undergraduate Degree
University of British Columbia	College/University	Hans S. Keirstead Nick Glover	Doctorate Degree Graduate Degree
Simon Fraser University	College/University	Nick Glover	Doctorate Degree
University of East Anglia	College/University	Nick Glover	Undergraduate Degree
University of Birmingham	College/University	John H. Abeles	Doctorate Degree
MedVest, Inc.		John H. Abeles	Founder
Combimatrix Molecular Diagnostics, Inc.		John H. Abeles	Director/Board Member
International University of Health Sciences	College/University	John H. Abeles	Corporate Officer/Principal
UniMedica, Inc.		John H. Abeles	Chairman
CONTRAFECT CORPORATION	Biotechnology	John H. Abeles	Founder
Etubics Corp. Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA.	Biotechnology	John H. Abeles	Director/Board Member
Baystar Biosciences		John H. Abeles	Director/Board Member
Medezrin Ltd.		John H. Abeles	Director/Board Member
Medisync Midwest LLC Medisync Midwest LLC Miscellaneous Commercial ServicesCommercial Services Medisync Midwest LLC provides consultation services. It offers practice management partnership, clinical research, volume to value planning, diagnostic assessments, and HCC program. The company is headquartered in Cincinnati, OH.	Miscellaneous Commercial Services	John H. Abeles	Director/Board Member
Higuchi Bioscience Center		John H. Abeles	Director/Board Member
SFC CO LTD	Containers/Packaging	Hans S. Keirstead	Director/Board Member
International Opera Alliance International Opera Alliance Miscellaneous Commercial ServicesCommercial Services International Opera Alliance is an entertainment company focused on musical and arts activities. The company is headquartered in Fairfax, VA.	Miscellaneous Commercial Services	John H. Abeles	Director/Board Member
Players Club		John H. Abeles	Corporate Officer/Principal
OHK Medical Devices, Inc. OHK Medical Devices, Inc. Medical SpecialtiesHealth Technology OHK Medical Devices, Inc. develops and manufactures self-contained, sterile, exsanguinating tourniquet products. Its products include hand and wrist, foot and ankle, upper extremity, lower extremity and pediatrics. The company was founded by Noam Gavriely in 1999 and is headquartered in Grandville, MI.	Medical Specialties	John H. Abeles	Director/Board Member
Dalyda Finance LLC		John H. Abeles	Corporate Officer/Principal
AEON Biopharma Sub, Inc. AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.	Pharmaceuticals: Other	Hans S. Keirstead	Director/Board Member
MEDITE CANCER DIAGNOSTICS INC	Medical Specialties	John H. Abeles	Director/Board Member
AiVita Biomedical, Inc. AiVita Biomedical, Inc. Pharmaceuticals: MajorHealth Technology AiVita Biomedical, Inc. operates as a therapeutic development company which focuses on regenerative and curative medicines. Its products include Provoque facial serum and Provoque eye complex. The company was founded by Hans S. Keirstead in 2016 and is headquartered in Irvine, CA.	Pharmaceuticals: Major	Hans S. Keirstead	Founder
Hadean Ventures AS Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway.	Investment Managers	John H. Abeles	Private Equity Investor
Bryologyx, Inc. Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA.	Pharmaceuticals: Major	John H. Abeles	Founder
Oncolyze, Inc. Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation.	Biotechnology	John H. Abeles	Founder
Immunis, Inc. Immunis, Inc. Miscellaneous Commercial ServicesCommercial Services Immunis, Inc. is a biotechnology company that focuses on developing innovative STEM treatments for immune decline related to age and disease, such as osteoporosis, osteoarthritis, and sarcopenia. The company is based in Irvine, CA. The company is currently conducting clinical trials for participants with leg muscle atrophy or weakness due to osteoarthritis/sarcopenia. Immunis aims to change the course of immune-related diseases and aging.	Miscellaneous Commercial Services	Hans S. Keirstead	Chairman